ClinicalTrials.gov
public full text
Public Domain
Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis
This study will be conducted to find out whether low dose or high dose cyclophosphamide therapy is effective in the treatment of proliferative lupus nephritis.It will also compare the side effects and risks of infection in low dose and high dose cyclophosphamide group. Half of the participants will receive a low dose cyclophosphamide for 3 months and half will receive high dose cyclophosphamide therapy monthly for 6 months followed by azathioprine 2 mg/kg.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- CYCLONES - CYClophosphamide LOw Dose and No Extra Steroid#1172560
- Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis#905104
- Clinical Trial Treatment in Lupus Nephritis#918434
- A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.#1031427
- Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone#1112465
Record · ID 1009250
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive